Conclusions The findings of this cohort study suggest that semaglutide is clinically effective for weight loss at 3 and 6 months for people with overweight or obesity
PlexusDx offers semaglutide and tirzepatide via its Weight Management Protocols, and its Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights so you and your provider start with more than a subscription form
But plausibility is not proof, and a mechanism observed in a culture dish is not a clinical outcome measured on a human scalp
With expert guidance and ongoing support, we help patients achieve safe, sustainable weight loss in a supportive, results-focused environment
Nonetheless, these potential benefits come with the need for careful assessment and management
Our Approach to Weight Management At Foundation Pain & Spine, we provide personalized programs at our center for weight management, designed to fit your unique needs and health goals